Vensica has in-licensed Venoxin, a premium botulinum toxin A, from a global pharma leader. Venoxin is the purest, and most stable, FDA approved toxin on the market.
Vensica has also developed, in-house, a minimally invasive, needle-free, Foley-like catheter to deliver the toxin into the bladder wall for the treatment of overactive bladder.
Botulinum Toxin A is highly efficacious in several bladder indications, including Overactive Bladder, Neurogenic Bladder, and Painful Bladder Syndrome. However, the toxin is currently injected into the bladder wall in an invasive procedure that involves side effects, pain and anesthesia.
Bladder cancer: in addition to toxin delivery, Vensica is also working to improve bladder cancer treatment with its proprietary platform.
We build a case to car
